1. Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics
   Panagiotis F. Christopoulos et al, 2018, Cancer Treatment Reviews CrossRef
2. Antagonist of Growth Hormone-Releasing Hormone Potentiates the Antitumor Effect of Pemetrexed and Cisplatin in Pleural Mesothelioma
   Iacopo Gesmundo et al, 2022, International Journal of Molecular Sciences CrossRef
3. Potentiation of cytotoxic chemotherapy by growth hormone-releasing hormone agonists
   Miklos Jaszberenyi et al, 2014, Proceedings of the National Academy of Sciences CrossRef
4. Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth
   Marta Zarandi et al, 2017, Peptides CrossRef
5. Growth hormone-releasing hormone induced transactivation of epidermal growth factor receptor in human triple-negative breast cancer cells
   Eva Vacas et al, 2016, Peptides CrossRef
6. Strategic Developments & Future Perspective on Gene Therapy for Breast Cancer: Role of mTOR and Brk/ PTK6 as Molecular Targets
   Roja Sahu et al, 2020, Current Gene Therapy CrossRef
7. The expression of GHRH and its receptors in breast carcinomas with apocrine differentiation—further evidence of the presence of a GHRH pathway in these tumors
   Bence Kővári et al, 2017, Human Pathology CrossRef
8. Potentiating effects of GHRH analogs on the response to chemotherapy
   Andrew V Schally et al, 2015, Cell Cycle CrossRef
9. Potential role for growth hormone-releasing hormone in triple-negative breast cancer
   Alice Lee, 2017, Peptides CrossRef
10. Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer
    Junnan Xu et al, 2017, Oncology Letters CrossRef
11. ROR activation by Nobiletin enhances antitumor efficacy via suppression of IκB/NF-κB signaling in triple-negative breast cancer
    Eunju Kim et al, 2022, Cell Death & Disease CrossRef
12. Differential immunostaining of various types of breast carcinomas for growth hormone‐releasing hormone receptor – Apocrine epithelium and carcinomas emerging as uniformly positive
    Bence Kővári et al, 2014, APMIS CrossRef
13. Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study
    Roberto Perez et al, 2014, Oncoscience CrossRef
14. Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells
    Woong Sub Byun et al, 2021, Biomedicines CrossRef
15. Novel GHRH antagonists suppress the growth of human malignant melanoma by restoring nuclear p27 function
    Luca Szalontay et al, 2014, Cell Cycle CrossRef
16. Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression
    Hsien-Ming Wu et al, 2017, Oncotarget CrossRef
17. Clinical studies in humans targeting the various components of the IGF system show lack of efficacy in the treatment of cancer
    Anastassios Philippou et al, 2017, Mutation Research/Reviews in Mutation Research CrossRef
18. Growth-hormone-releasing Hormone as a Prognostic Biomarker and Therapeutic Target in Gastrointestinal Cancer
    Amir Avan et al, 2023, Current Cancer Drug Targets CrossRef
19. Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancer
    Laura Muñoz-Moreno et al, 2016, Oncotarget CrossRef
20. Expression of Receptors for Pituitary-Type Growth Hormone-Releasing Hormone (pGHRH-R) in Human Papillary Thyroid Cancer Cells: Effects of GHRH Antagonists on Matrix Metalloproteinase-2
    Paola Catanuto et al, 2015, Hormones and Cancer CrossRef
21. New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor
    Rosemeire M. Kanashiro-Takeuchi et al, 2015, Oncotarget CrossRef
22. Tackling breast cancer chemoresistance with nano-formulated siRNA
    S K Jones et al, 2016, Gene Therapy CrossRef